Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

High consumption of ultraprocessed foods containing high levels of added sugars, saturated fat, and sodium is associated with obesity in early childhood, especially in boys.

Children’s eating habits are strongly influenced by their parents' weight status, with those having overweight or obese ...

More than 40 percent of Qataris are clinically obese, due to sedentary lifestyles, genetic factors, and cultural preferences ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Patients who bought stockpiles of alternative GLP-1 drugs online aren't sure what to do with them after learning that the ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

The North Dakota legislature proposed a new bill that would require state Medicaid to fully cover obesity treatments, including therapy, surgery, and FDA-approved medications.

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...